Travere Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 11.42 M | $339.25 M | 8.64% | 12.43% |
| FMR LLC | 05/15/2026 | 10.97 M | $325.86 M | 14.04% | 11.94% |
| BLACKROCK, INC. | 05/13/2026 | 7.79 M | $231.50 M | -0.98% | 8.48% |
| STATE STREET CORP | 05/15/2026 | 4.96 M | $147.36 M | 4.27% | 5.40% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 4.90 M | $145.50 M | 30.12% | 5.33% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 4.14 M | $123.08 M | -3.17% | 4.51% |
| 05/15/2026 | 4.05 M | $120.20 M | 100.00% | 4.40% | |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 3.27 M | $97.17 M | -13.33% | 3.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.37 M | $70.41 M | 10.55% | 2.58% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 1.97 M | $58.43 M | -12.46% | 2.14% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 04/28/2026 | 1.80 M | $53.43 M | 4.46% | 1.96% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.72 M | $51.09 M | -7.95% | 1.87% |
| 05/08/2026 | 1.71 M | $50.78 M | 100.00% | 1.86% | |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 1.57 M | $46.62 M | 202.97% | 1.71% |
| EMERALD ADVISERS, LLC | 05/04/2026 | 1.56 M | $46.26 M | -2.32% | 1.70% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.51 M | $44.81 M | 30.38% | 1.64% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 1.48 M | $43.91 M | -33.13% | 1.61% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.35 M | $39.96 M | -27.31% | 1.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.28 M | $38.10 M | 42.28% | 1.40% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.13 M | $33.67 M | 100.00% | 1.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 1.02 M | $30.37 M | 27.95% | 1.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 977.00 K | $29.03 M | -66.62% | 1.06% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 05/04/2026 | 945.03 K | $28.08 M | -0.36% | 1.03% |
| NUVEEN, LLC | 04/30/2026 | 938.57 K | $27.88 M | -5.54% | 1.02% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 925.92 K | $27.51 M | 5.02% | 1.01% |
| FIERA CAPITAL CORP | 05/12/2026 | 900.87 K | $26.76 M | 3.07% | 0.98% |
| UBS GROUP AG | 05/05/2026 | 856.76 K | $25.45 M | 102.73% | 0.93% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 836.54 K | $24.85 M | -23.57% | 0.91% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 800.00 K | $23.77 M | 100.00% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 790.81 K | $23.50 M | -2.15% | 0.86% |
| NORTHERN TRUST CORP | 05/14/2026 | 781.42 K | $23.22 M | 2.62% | 0.85% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 746.84 K | $22.19 M | 100.00% | 0.81% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 715.71 K | $21.26 M | -11.12% | 0.78% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 681.00 K | $20.23 M | 2.19% | 0.74% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 677.10 K | $20.12 M | -5.75% | 0.74% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 669.16 K | $19.88 M | 64.73% | 0.73% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 612.62 K | $18.20 M | 100.00% | 0.67% |
| BARCLAYS PLC | 05/15/2026 | 610.60 K | $18.14 M | 188.02% | 0.66% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 592.91 K | $17.62 M | 0.95% | 0.65% |
| ABRDN PLC | 04/29/2026 | 557.15 K | $16.55 M | 7.48% | 0.61% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 546.00 K | $16.22 M | 100.00% | 0.59% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 542.61 K | $16.12 M | -53.82% | 0.59% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 529.76 K | $14.68 M | -0.91% | 0.58% |
| INVESCO LTD. | 05/12/2026 | 523.71 K | $15.56 M | 10.47% | 0.57% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 520.60 K | $15.47 M | 100.00% | 0.57% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 451.06 K | $13.40 M | -15.99% | 0.49% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 404.81 K | $12.03 M | 2.52% | 0.44% |
| HSBC HOLDINGS PLC | 04/30/2026 | 396.85 K | $11.79 M | 100.00% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 376.70 K | $11.19 M | 234.84% | 0.41% |
| CANDRIAM S.C.A. | 04/30/2026 | 370.00 K | $10.99 M | -21.04% | 0.40% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Travere Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 363 institutional investors and hedge funds held shares of Travere Therapeutics Inc. The most heavily invested institutionals were:
Stephens Investment Management Group LLC: 1.88 M
EMERALD ADVISERS, LLC: 1.6 M
EMERALD MUTUAL FUND ADVISERS TRUST: 1.03 M
PANAGORA ASSET MANAGEMENT INC: 490,724
Assenagon Asset Management S.A.: 427,305
Russell Investments Group, Ltd.: 395,969
110.33% of Travere Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 117.37 M shares in the last 24 months. This purchase volume represents approximately $3.40 B in transactions.